Domov › Alzheimerjeva bolezen › Arizona
Klinične študije za Alzheimerjeva bolezen v Arizona
23 študij za Alzheimerjeva bolezen išče udeležence na lokacijah v Arizona.
Mesta v Arizona
Uradno besedilo študije (angleško)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Phoenix
- Clinical Site, Scottsdale
- Clinical Site, Tucson
Vključevanje udeležencevFaza 2
Starost 55–90 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2609, Chandler
- Imaging Endpoints, Scottsdale
Vključevanje udeležencevFaza 3
Starost 55–90 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06937229A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- TrialSphere Corp, Chandler
- HonorHealth Research Institute, Scottsdale
Vključevanje udeležencevFaza 2
Starost 55–85 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Gilbert Neurology Partners - PLLC - Avacare, Gilbert
- Banner Alzheimer's Institute, Phoenix
Vključevanje udeležencevFaza 3
Starost 55–90 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Banner Alzheimer's Institute, Phoenix
- Barrow Neurological Institute, Phoenix
- Clinical Endpoints, Scottsdale
Vključevanje udeležencevFaza 2
Starost 55–80 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Banner Alzheimer?s Institute, Phoenix
- Banner Sun Health Research Institute, Sun City
Vključevanje udeležencevFaza 3
Starost 50–90 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Chandler Clinical Trials, LLC, Chandler
- Local Institution - 2631, Chandler
- TrialSphere Corp, Chandler
Vključevanje udeležencevFaza 3
Starost 55–90 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Imaging Endpoints, Scottsdale
Vključevanje udeležencevFaza 3
Starost 55–90 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07011732Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0040, Scottsdale
Vključevanje udeležencevFaza 2
Starost 55–90 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT06808984A Study of AMDX-2011P in Participants With Alzheimer's Disease
- Associated Retina Consultants, Phoenix
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT06514001The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
- University of Arizona, Tucson
Vključevanje udeležencev
Starost 55–85 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT05988385Goal Setting to Promote Physical Activity Adherence in Midlife Adults
- Arizona State University, Phoenix
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 45–65 · Vsi spoli · Posodobljeno 17. jul. 2026 · NCT05980052A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Banner Alzheimer's Institute, Phoenix
Vključevanje udeležencevFaza 3
Starost 55 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT07602582A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Gilbert Neurology Partners/CCT Research, Gilbert
Vključevanje udeležencevFaza 3
Starost 55–90 · Vsi spoli · Posodobljeno 30. jun. 2026 · NCT06947941A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- Banner Alzheimers Institute, Phoenix
Vključevanje udeležencevFaza 2
Starost 50–85 · Vsi spoli · Posodobljeno 26. jun. 2026 · NCT07094516[18F]PI-2620 Phase 3 Histopathological Study
- Barrow Neurological Institute, Phoenix
- Banner Sun Health Research Institute, Sun City
Vključevanje udeležencevFaza 3
Starost 50 in več · Vsi spoli · Posodobljeno 22. maj 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Barrow Neurological Institute, Phoenix
Vključevanje udeležencevOpazovalna študija
Starost 25–55 · Vsi spoli · Posodobljeno 18. maj 2026 · NCT04165109A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
- Arizona State University, Phoenix
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 65 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT05877196Early-Stage Partner in Care Living Alone Plus
- Arizona State University, Phoenix
Vključevanje udeležencev
Starost 60 in več · Vsi spoli · Posodobljeno 27. mar. 2026 · NCT06962111Repurposing Siponimod for Alzheimer's Disease
- St. Joseph's Hospital and Medical Center, Phoenix
Vključevanje udeležencevFaza 2
Starost 50–85 · Vsi spoli · Posodobljeno 4. mar. 2026 · NCT06639282A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
- Mayo Clinic Arizona, Scottsdale
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 50–95 · Vsi spoli · Posodobljeno 3. feb. 2026 · NCT06057909Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
- Banner Alzheimer's Institute, Phoenix
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18–110 · Vsi spoli · Posodobljeno 16. dec. 2025 · NCT02022943PROMIS and Mobility Evaluation in Sarcoma Patients
- Mayo Clinic, Phoenix
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 13. nov. 2025 · NCT07227961Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.